IM Cannabis
IMCC
6 hedge funds and large institutions have $10.5K invested in IM Cannabis in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 4 closing their positions.
2.94% less ownership
Funds ownership: 3.42% → 0.48% (-2.9%)
40% less funds holding
Funds holding: 10 → 6 (-4)
96% less capital invested
Capital invested by funds: $249K → $10.5K (-$239K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
-$142K |
| 2 |
HBCM
Heron Bay Capital Management
Bloomfield Hills,
Michigan
|
-$36K |
| 3 |
DS
DRW Securities
Chicago,
Illinois
|
-$32.1K |
| 4 |
Morgan Stanley
New York
|
-$139 |
IMCC Hedge Fund Activity: Q1 2026 in Review
6 of the 8,198 institutional investors tracked by Wall St. Rank reported a position in IM Cannabis (IMCC) for Q1 2026, worth a combined $10.5K — down 96% from $249K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of IMCC and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was AdvisorShares Investments, exiting entirely with an estimated $142K sold.
- 6 institutional investors held IM Cannabis (IMCC) as of Q1 2026, down from 10 in Q4 2025.
- Funds reported $10.5K of IM Cannabis stock for Q1 2026, down 96% quarter-over-quarter.
- 0 funds opened new IM Cannabis positions in Q1 2026 and 4 closed out, a net change of -4 holders.
- The largest IM Cannabis seller in Q1 2026 was AdvisorShares Investments, an estimated $142K sold.
Based on aggregated 13F filings for Q1 2026.